PHASE-II EVALUATION OF DIANHYDROGALACTITOL IN THE TREATMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

被引：0
|
作者：
STEHMAN, FB
BLESSING, JA
DELGADO, G
LOUKA, M
机构：
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,GYNECOL ONCOL GRP,HEADQUARTERS OFF,PHILADELPHIA,PA 19107
[2] GEORGETOWN UNIV HOSP,WASHINGTON,DC 20007
[3] HAHNEMANN MED COLL & HOSP,PHILADELPHIA,PA 19102
[4] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46204
[5] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF PIPERAZINEDIONE IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    PETTY, W
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 21 - 23
  • [2] METHOTREXATE IN ADVANCED ENDOMETRIAL CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    BLESSING, JA
    HATCH, KD
    SOPER, JT
    WEBSTER, KD
    KEMP, GM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 61 - 63
  • [3] CIS-PLATINUM IN THE TREATMENT OF ADVANCED OR RECURRENT ADENOCARCINOMA OF THE OVARY - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    THIGPEN, JT
    LAGASSE, L
    HOMESLEY, H
    BLESSING, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 431 - 435
  • [4] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    DELGADO, G
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1669 - 1671
  • [5] MITOXANTRONE IN THE TREATMENT OF ADVANCED UTERINE SARCOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    BUNDY, BN
    ADCOCK, L
    BEECHAM, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 32 - 34
  • [6] PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN REFRACTORY ADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SUTTON, GP
    BLESSING, JA
    HOMESLEY, HD
    MCGUIRE, WP
    ADCOCK, L
    CANCER, 1994, 73 (05) : 1453 - 1455
  • [7] ECHINOMYCIN IN RECURRENT AND METASTATIC ENDOMETRIAL CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    BLESSING, JA
    DUBESHTER, B
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 492 - 493
  • [8] PHASE-II CLINICAL-STUDY OF TAMOXIFEN IN ADVANCED ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAVIK, M
    PETTY, WM
    BLESSING, JA
    CREASMAN, WT
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1984, 68 (05): : 809 - 811
  • [9] PHASE-II STUDY OF FAZARABINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MANETTA, A
    BLESSING, JA
    LOOK, KY
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02): : 156 - 157
  • [10] CIS-DICHLORODIAMMINEPLATINUM(II) IN THE TREATMENT OF GYNECOLOGIC MALIGNANCIES - PHASE-II TRIALS BY THE GYNECOLOGIC-ONCOLOGY-GROUP
    THIGPEN, T
    SHINGLETON, H
    HOMESLEY, H
    LAGASSE, L
    BLESSING, J
    CANCER TREATMENT REPORTS, 1979, 63 (9-10): : 1549 - 1555
12345